Join Growin Stock Community!

Masimo corporationMASI.US Overview

US StockHealthcare
(No presentation for MASI)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

MASI AI Insights

MASI Overall Performance

MASI AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MASI Recent Performance

0.05%

Masimo corporation

0.05%

Avg of Sector

-0.31%

S&P500

MASI PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

MASI Key Information

MASI Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

MASI Profile

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Price of MASI

MASI FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MASI Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.82
PE Ratio (TTM)
-
Forward PE
29.54
PS Ratio (TTM)
4.32
PB Ratio
11.62
Price-to-FCF
43.22
METRIC
VALUE
vs. INDUSTRY
Gross Margin
61.90%
Net Margin
-9.92%
Revenue Growth (YoY)
-27.10%
Profit Growth (YoY)
-5.89%
3-Year Revenue Growth
-12.56%
3-Year Profit Growth
-7.59%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.82
PE Ratio (TTM)
-
Forward PE
29.54
PS Ratio (TTM)
4.32
PB Ratio
11.62
Price-to-FCF
43.22
Gross Margin
61.90%
Net Margin
-9.92%
Revenue Growth (YoY)
-27.10%
Profit Growth (YoY)
-5.89%
3-Year Revenue Growth
-12.56%
3-Year Profit Growth
-7.59%

  • When is MASI's latest earnings report released?

    The most recent financial report for Masimo corporation (MASI) covers the period of 2025Q4 and was published on 2026/01/03. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MASI's short-term business performance and financial health. For the latest updates on MASI's earnings releases, visit this page regularly.

  • What is the operating profit of MASI?

    According to the latest financial report, Masimo corporation (MASI) reported an Operating Profit of 83.9M with an Operating Margin of 20.34% this period, representing a growth of 123.36% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is MASI's revenue growth?

    In the latest financial report, Masimo corporation (MASI) announced revenue of 412.5M, with a Year-Over-Year growth rate of -31.33%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does MASI have?

    At the end of the period, Masimo corporation (MASI) held Total Cash and Cash Equivalents of 152.3M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does MASI go with three margins increasing?

    In the latest report, Masimo corporation (MASI) achieved the “three margins increasing” benchmark, with a gross margin of 60%%, operating margin of 20.34%%, and net margin of 16.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MASI's profit trajectory and future growth potential.

  • Is MASI's EPS continuing to grow?

    According to the past four quarterly reports, Masimo corporation (MASI)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.23. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of MASI?

    Masimo corporation (MASI)'s Free Cash Flow (FCF) for the period is 53.4M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 28.67% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of MASI?

    The latest valuation data shows Masimo corporation (MASI) has a Price-To-Earnings (PE) ratio of -60.41 and a Price/Earnings-To-Growth (PEG) ratio of -0.15. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.